|
Avaliação DCF da China Holdings Limited Limited (3900.HK)
CN | Real Estate | Real Estate - Development | HKSE
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Greentown China Holdings Limited (3900.HK) Bundle
Projetado para precisão, nossa calculadora DCF (3900HK) permite avaliar a avaliação da Greentown China Holdings Limited usando dados financeiros do mundo real, oferecendo flexibilidade completa para modificar todos os parâmetros essenciais para obter previsões aprimoradas.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 65,767.2 | 70,240.7 | 107,033.5 | 135,770.4 | 140,287.2 | 171,626.8 | 209,967.5 | 256,873.3 | 314,257.8 | 384,461.7 |
| Revenue Growth, % | 0 | 6.8 | 52.38 | 26.85 | 3.33 | 22.34 | 22.34 | 22.34 | 22.34 | 22.34 |
| EBITDA | 9,869.3 | 9,445.2 | 11,241.9 | 15,137.4 | 14,329.9 | 20,705.2 | 25,330.7 | 30,989.4 | 37,912.3 | 46,381.8 |
| EBITDA, % | 15.01 | 13.45 | 10.5 | 11.15 | 10.21 | 12.06 | 12.06 | 12.06 | 12.06 | 12.06 |
| Depreciation | 649.9 | 626.6 | 659.3 | 814.6 | 832.5 | 1,266.5 | 1,549.4 | 1,895.5 | 2,319.0 | 2,837.0 |
| Depreciation, % | 0.98821 | 0.89208 | 0.61593 | 0.59998 | 0.59343 | 0.73793 | 0.73793 | 0.73793 | 0.73793 | 0.73793 |
| EBIT | 9,219.3 | 8,818.6 | 10,582.7 | 14,322.8 | 13,497.4 | 19,438.7 | 23,781.3 | 29,093.9 | 35,593.3 | 43,544.8 |
| EBIT, % | 14.02 | 12.55 | 9.89 | 10.55 | 9.62 | 11.33 | 11.33 | 11.33 | 11.33 | 11.33 |
| Total Cash | 49,723.7 | 63,583.0 | 73,090.7 | 70,941.4 | 74,531.2 | 116,635.3 | 142,691.1 | 174,567.8 | 213,565.5 | 261,275.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 13,583.0 | 17,437.7 | .0 | .0 | 12,230.0 | 14,962.1 | 18,304.6 | 22,393.8 | 27,396.4 |
| Account Receivables, % | 0 | 19.34 | 16.29 | 0 | 0 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 |
| Inventories | 192,086.1 | 248,935.3 | 304,376.2 | 303,970.6 | 305,930.5 | 171,626.8 | 209,967.5 | 256,873.3 | 314,257.8 | 384,461.7 |
| Inventories, % | 292.07 | 354.4 | 284.37 | 223.89 | 218.07 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 33,295.3 | 38,129.4 | 49,884.6 | 50,955.9 | 51,909.2 | 77,592.3 | 94,926.1 | 116,132.2 | 142,075.6 | 173,814.7 |
| Accounts Payable, % | 50.63 | 54.28 | 46.61 | 37.53 | 37 | 45.21 | 45.21 | 45.21 | 45.21 | 45.21 |
| Capital Expenditure | -600.6 | -552.3 | -538.7 | -420.4 | -383.9 | -956.3 | -1,169.9 | -1,431.3 | -1,751.0 | -2,142.2 |
| Capital Expenditure, % | -0.91319 | -0.78628 | -0.50327 | -0.30962 | -0.27365 | -0.5572 | -0.5572 | -0.5572 | -0.5572 | -0.5572 |
| Tax Rate, % | 67.94 | 67.94 | 67.94 | 67.94 | 67.94 | 67.94 | 67.94 | 67.94 | 67.94 | 67.94 |
| EBITAT | 1,105.4 | 2,028.5 | 2,743.9 | 2,977.8 | 4,327.2 | 4,423.1 | 5,411.2 | 6,620.0 | 8,098.9 | 9,908.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -157,636.1 | -63,495.3 | -44,676.0 | 22,286.8 | 3,769.1 | 152,490.2 | -17,948.4 | -21,958.0 | -26,863.3 | -32,864.4 |
| WACC, % | 1.38 | 1.8 | 1.91 | 1.72 | 2.15 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 56,576.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -33,522 | |||||||||
| Terminal Value | 16,263,779 | |||||||||
| Present Terminal Value | 14,880,344 | |||||||||
| Enterprise Value | 14,936,920 | |||||||||
| Net Debt | 82,182 | |||||||||
| Equity Value | 14,854,738 | |||||||||
| Diluted Shares Outstanding, MM | 2,533 | |||||||||
| Equity Value Per Share | 5,865.15 |
What You Will Receive
- Accurate 3900HK Financials: Access to historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures with ease.
- Dynamic Calculations: Intrinsic value and NPV are calculated in real-time.
- Scenario Testing: Analyze various scenarios to assess Greentown China's future prospects.
- User-Friendly Interface: Designed for professionals but easy enough for newcomers to navigate.
Key Features
- Comprehensive 3900HK Data: Pre-loaded with Greentown China Holdings Limited's historical financials and future projections.
- Fully Adjustable Inputs: Modify key variables such as revenue growth, profit margins, WACC, tax rates, and capital expenditures to suit your analysis.
- Dynamic Valuation Framework: Instantaneous updates to Net Present Value (NPV) and intrinsic value in response to your input changes.
- Scenario Analysis: Construct various forecasting scenarios to explore different valuation possibilities.
- Intuitive Interface: Designed for ease of use, making it accessible for both professionals and newcomers.
How It Functions
- Download the Template: Gain immediate access to the Excel-based DCF Calculator for Greentown China Holdings Limited (3900HK).
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key factors.
- Instant Calculations: The model automatically recalculates the intrinsic value of Greentown China Holdings Limited (3900HK).
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis decisions.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and consultants.
- Up-to-Date Data: Historical and projected financials of Greentown China Holdings Limited (3900HK) preloaded for precision.
- Forecast Simulations: Effortlessly test various scenarios and assumptions.
- Comprehensive Outputs: Instantly computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Clear, step-by-step guidance simplifies the process.
Who Should Benefit from This Product?
- Individual Investors: Make informed decisions when buying or selling shares of Greentown China Holdings Limited (3900HK).
- Financial Analysts: Enhance your valuation processes with pre-built financial models tailored for Greentown China Holdings Limited (3900HK).
- Consultants: Provide clients with accurate and timely valuation insights regarding Greentown China Holdings Limited (3900HK).
- Business Owners: Gain a deeper understanding of how major companies like Greentown China Holdings Limited (3900HK) are valued to inform your strategic planning.
- Finance Students: Develop valuation skills using real data and case studies related to Greentown China Holdings Limited (3900HK).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Greentown China Holdings Limited (3900HK), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A specific sheet dedicated to the Weighted Average Cost of Capital (WACC), detailing parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that illustrate intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate analysis.
- Key Ratios: Incorporates profitability, leverage, and efficiency ratios relevant to Greentown China Holdings Limited (3900HK).
- Dashboard and Charts: A visual representation of valuation outputs and assumptions for straightforward analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.